Biotech News


EPA says Roundup is safe, non-carcinogenic

Oct 19, 2016

Major governments around the world, including the European Union and European Food Safety Authority, have refuted the IARC conclusion that there is a link between the herbicide and cancer.

YANKTON, S.D. — The U.S. Environmental Protection Agency has determined glyphosate, or Roundup, is safe and not carcinogenic to humans. The conclusion was included in an herbicide-focused study posted to a federal regulatory website Sept. 16. 

EPA says “an extensive database” was used for evaluating glyphosate, which included 23 epidemiological studies, 15 animal carcinogenicity studies and about 90 genotoxicity studies. As a result, the agency concluded, “The available data at this time do not support a carcinogenic process for glyphosate.”

In an interview regarding the agency’s position on the most widely used herbicide in the world, EPA Agriculture Counselor Ron Carleton says, “Our view at this point, is that glyphosate when used according to label is safe and effective.”  

The EPA paper precedes scientific advisory panel meeting on glyphosate, which will be held Oct. 18 to 21 in Washington, D.C. It also disputes the March 2015 findings from the International Agency for Research on Cancer, which determined various research studies indicated that glyphosate is “probably carcinogenic to humans.”

The newest findings by EPA come as no surprise to industry officials. Jay Vroom, CEO of CropLife America, the Washington D.C.-based trade group representing the agricultural chemical industry says, “It’s been evaluated around the world and registered as safe to be used by countless countries.”  The organization’s Senior Vice President of Science and Regulatory Affairs, Janet Collins, says, “The bigger surprise was why are we having this discussion again when EPA had just finished its cancer repot the middle of last year? So the question was, what’s new? And so they do go through in pretty good detail, the ‘what’s new.’ The studies that they had not reviewed before, both from a toxicology perspective, as well as epidemiologic studies.”

Finish the article at